ArticleFrontiers in bioengineering and biotechnology2026
Platelet-rich plasma for the treatment of a pressure wound: a case report and review of the literature.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prolonged bed rest leads to pressure wounds with skin infections and difficulties in long-term wound healing. Platelet-rich plasma (PRP) contains high concentrations of platelets and is used to promote chronic wound healing. Objective: In this patient, PRP was used several times to promote the healing of a chronic pressure wound. Case Report: The patient presented with a decreased level of consciousness. Due to prolonged bed rest, a pressure wound and skin infection developed. The pressure wound was cleansed daily with iodophor, filled with alginate, and covered with a foam dressing for approximately 5 months; however, the wound did not heal. After assessment of the patient's physical condition, autologous PRP was used in the treatment. A total of 150 mL of peripheral blood was collected from the patient for the preparation of autologous PRP. After debridement, autologous PRP and an activator (thrombin and 10% calcium chloride) were mixed in a 10:1 volume ratio and sprayed onto the surface of the pressure wound, and was given a sterile oiled gauze and gauze coverage with foam dressing for protection. After eight PRP treatments, the pressure ulcer healed within 3 months. Conclusion: The patient's outcome suggests that PRP may be a promising adjunctive therapy for patients with nonhealing pressure ulcers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.